Rituximab Market Share

  • Report ID: 3315
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Rituximab Market Share

North American Market Forecast

North America industry is anticipated to dominate majority revenue share of 45% by 2037, In addition, market growth is expected to be fuelled by increased government spending on cancer research as well as the presence of major pharmaceutical companies such as Pfizer Inc., Amgen Inc., and Merck & Co.

APAC Market Statistics

The Asia Pacific region is expected to hold the second-largest position in the rituximab market. In view of rising disposable incomes, availability of a large patient population for monoclonal antibody cancer treatments, and increased focus on healthcare, the Asia Pacific region is expected to show the highest growth rate during the forecast period at 12.1%. As well as providing investment opportunities in clinical research, countries such as India and China are expected to have a positive impact on the R&D prospects for monoclonal antibodies.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3315
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of rituximab is estimated at USD 5.11 billion.

The rituximab market size was over USD 4.03 billion in 2024 and is anticipated to cross USD 27.13 billion by 2037, witnessing more than 15.8% CAGR during the forecast period i.e., between 2025-2037. Increasing demand for monoclonal antibodies, increasing collaborations for the development of new products and investment in healthcare sector will drive the market growth.

North America industry is anticipated to dominate majority revenue share of 45% by 2037, fuelled by increased government spending on cancer research as well as the presence of major pharmaceutical companies in the region.

The major players in the market are Amgen Inc, Henlius Biotech, Inc., Nordic Nanovector ASA, Biocon Biologics Ltd, Pfizer Inc., Chugai Pharmaceuticals, Zenyaku Kogyo Co. Ltd, SymBio Pharmaceuticals, Daiichi Sankyo, Kyowa Kirin Co. Ltd
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample